The global angiography imaging systems market size reached USD 5.5 Bn in 2021. The demand for angiography imaging systems is estimated to total USD 5.8 Bn by 2022, projecting growth at a CAGR of around 6% to 7% during the assessment period 2022 to 2032. The sales of angiography imaging systems are expected to surpass a valuation of USD 9.5 Bn by the end of 2032.
| Report Attribute | Details |
|---|---|
| Angiography Imaging Systems Market Registered Base Value (2021) | USD 5.5 Billion |
| Angiography Imaging Systems Market Expected Value (2022) | USD 5.8 Billion |
| Angiography Imaging Systems Market Anticipated Value (2032) | USD 9.5 Billion |
| Angiography Imaging Systems Market Projected Growth Rate (2022 to 2032) | 6% to 7% CAGR |
Angiography is a type of medical imaging technique used to visualize the inside of the body organ and blood vessels especially veins, arteries, and heart chambers. Angiography imaging systems includes X-Ray machines, computed tomography (CT) scanner, magnetic resonance imaging (MRI) system, and others that are used to perform angiography.
Over the past couple of years, a significant rise in the burden of cardiovascular diseases such as arrhythmias, heart attack, stroke, deep vein thrombosis, and others is being witnessed across the world, due to the increasing tobacco use, smoking, alcohol abuse, and others. This is creating strong demand for associate diagnosis and treatment solutions.
For instance, according to a study by the World Health Organization (WHO), cardiovascular diseases are considered as the leading cause of death worldwide, accounting for around 17.9 Mn fatalities due to the diseases in the year 2019.
As angiography imaging systems play a vital role in the diagnosis of various critical conditions such as arrhythmias, heart attack, stroke, and others, the increasing prevalence of cardiovascular diseases is expected to create growth prospects in the global market.
Despite various advantages associated with the use of angiography imaging systems, extravagant cost of the angiography procedures, unsuitability for critically ill patients, and high risk of injury due to catheterized artery among others is impeding the growth in the global market.
In addition to this, growing patient inclination toward adopting minimally invasive medical imaging solutions and the high cost of angiography imaging systems are further hindering the sales in the market.
As the FMI, North America is expected to register robust growth in the global angiography imaging systems market during the forecast period 2022-2032.
Due to the growing obesity, increasing consumption of alcohol, growing bad eating habits, there is a swift rise in burden of kidney and heart-related disorders across North America. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 1 out of 7 adults, or nearly 37 million people across the U.S. are reported to be having chronic kidney diseases.
As angiography imaging systems are extensively used for visualizing the blood vessels in the kidneys and heart for the assessment and identification of the complications, rising incidence of such diseases is estimated to favor the growth in the North America market.
Western Europe is expected to account for a significant share in the global angiography imaging systems market from 2022 to 2032, states Future Market Insights.
As the prevalence of disorders related to heart, brain, kidney, and blood vessels continues to rise along with increasing adoption of angiography procedures, there is a rapid surge in demand for angiography imaging systems. Hence, key players in the market are aiming at receiving regulatory approvals for introducing novel products to cater to the growing demand.
For instance, in 2019, Siemens Healthineers, a German medical device company announced receiving Food and Drug Administration (FDA) 510(k) clearance for its new high-precision angiography system, ARTIS icono. A slew of such developments is projected to accelerate the sales in the Western Europe market.
Some of the leading players in the angiography imaging systems market are Omega Medical Imaging LLC, Siemens AG, Shimadzu Corporation, Koninklijke Philips N.V., Canon Inc., and others.
Prominent players in the global market are focusing at introducing novel products and entering into collaboration, partnership, and acquisition to gain edge in the highly competitive market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6% to 7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Technology, Application, End User, Region |
| Countries Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Companies Profiled | Omega Medical Imaging LLC; Siemens AG; Shimadzu Corporation; Koninklijke Philips N.V.; Canon Inc; Others |
| Customization | Available Upon Request |
FMI projects the sales of angiography imaging systems in the market is expected to rise at 6% to 7% value CAGR by 2032
The global angiography imaging systems market is expected to be dominated by North America over the forecast period 2022-2032.
Omega Medical Imaging LLC, Siemens AG, Shimadzu Corporation, Koninklijke Philips N.V., Canon Inc., and others are some of the leading players in the prominent angiography imaging systems market.
Explore Similar Insights
Angiography Imaging Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
